Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
DOI10.1515/IJNSNS-2015-0051zbMATH Open1401.92100OpenAlexW2523272718MaRDI QIDQ1661641FDOQ1661641
Authors: Sonia Chowdhury, Priti Kumar Roy, Robert Smith 
Publication date: 16 August 2018
Published in: International Journal of Nonlinear Sciences and Numerical Simulation (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1515/ijnsns-2015-0051
Recommendations
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor
- Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: the role of fusion inhibitors in HAART
Medical applications (general) (92C50) Medical epidemiology (92C60) Qualitative investigation and simulation of ordinary differential equation models (34C60) Ordinary differential equations with impulses (34A37) Stability of solutions to ordinary differential equations (34D20)
Cites Work
- Title not available (Why is that?)
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Title not available (Why is that?)
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
- Title not available (Why is that?)
- Title not available (Why is that?)
- Drug concentration heterogeneity facilitates the evolution of drug resistance
- A MODEL FOR CONTROL OF HIV/AIDS WITH PARENTAL CARE
- The failure of \(R_{0}\)
- Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection
- Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
- Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- A MATHEMATICAL MODEL ON CTL MEDIATED CONTROL OF HIV INFECTION IN A LONG-TERM DRUG THERAPY
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Saturation effects for CTL mediated control of HIV-1 infection: a mathematical study
- A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection
- CTL Response Suppression in Chronic Phase of Infection:A mathematical study
Cited In (10)
- Modelling two different therapy strategies for drug T-20 on HIV-1 patients
- Two-way Bayesian hierarchical phylogenetic models: an application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
- Analysis of HIV latent infection model with multiple infection stages and different drug classes
- MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV
- The Impact of Vaccination to Control Human Papillomavirus Dynamics
- Mathematical modeling for the prevention of methanol poisoning through ethanol by impulsive way
- Impact of combined therapy in HIV-1 treatment: a double impulsive approach
- Role of antibiotic therapy in bacterial disease: A mathematical study
- How can HPV-induced cervical cancer be controlled by a combination of drug therapy? A mathematical study
- Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model
This page was built for publication: Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1661641)
